Maximizing Infiltration Treatment outcome: A randomized controlled trial of patients with lower back pain

Maximizing Infiltration Treatment outcome: A randomized controlled trial of patients with lower back pain - MITO RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032368

Enrollment

200

Registered

2023-08-17

Start date

2023-10-30

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower back pain

Interventions

Group 1: Participants of the intervention group will receive a non-pharmacological digitally supported expectation-focused self-care intervention (dEFSCI) before the infiltration treatment. The dEFSCI

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - are undergoing infiltration therapy due to low back pain - are fluent in German

Exclusion criteria

Exclusion criteria: Patients with a psychosis or schizophrenic disorder, who are in the process of an ongoing disability insurance application, have no e-mail address and / or show further reason, which would prevent participation in the study (e.g. insufficient knowledge on how to use a digital intervention) will be excluded.

Design outcomes

Primary

Measure	Time frame
Patients’ subjectively experienced pain intensity (Numeric Rating Scale, NRS, 7 days recall period) 2 weeks post-treatment (T2)	—

Secondary

Measure	Time frame
Patients’ subjective treatment expectations (Expectation for Treatment Scale, ETS a.o.) at baseline and after exposure to the dEFSCI before the infiltration procedure (Baseline, T1)	—

Countries

Switzerland

Contacts

Public ContactZina-Mary Manjaly

Schulthess Klinik

zina-mary.manjaly@kws.ch+41443857475

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026